Encorafenib

• Description :

  LGX818 is an orally available mutated BRaf V600E inhibitor (IC50=0.3 nM) with potential antineoplastic activity.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  540.01

• Molecular Formula :

  C22H27ClFN7O4S

• Notes :

  Research use only, not for human use.

• Receptor :

  B-Raf (V600E)

• CAS Number :

  1269440-17-6